|
|
Article: Targeted therapies promise new hope for brain cancer patients; Datamonitor.
- Article from:
- Pharma Marketletter
- Article date:
- October 1, 2007
CopyrightCOPYRIGHT 2007 Marketletter Publications Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Despite the many millions of dollars being invested into brain cancer research, primary brain cancer remains one of the most deadly diseases in the developed world.
While primary brain tumors are relatively rare, the chances of survival for patients with the disease are very low, even with the best treatment options currently available. According to a new report from Datamonitor, however, significant progress is being made with research into the disease and innovative new therapies may be able to improve survival of brain cancer patients.
Deadly disease
The most aggressive and common form of brain cancer is known as glioblastoma multiforme, ...